| Year |
Citation |
Score |
| 2021 |
Budzik KM, Nace RA, Ikeda Y, Russell SJ. Oncolytic Foamy Virus - generation and properties of a nonpathogenic replicating retroviral vector system that targets chronically proliferating cancer cells. Journal of Virology. PMID 33692205 DOI: 10.1128/JVI.00015-21 |
0.307 |
|
| 2019 |
Zhu Y, Tonne JM, Liu Q, Schreiber CA, Zhou Z, Rakshit K, Matveyenko AV, Terzic A, Wigle D, Kudva YC, Ikeda Y. Targeted Derivation of Organotypic Glucose- and GLP-1-Responsive β Cells Prior to Transplantation into Diabetic Recipients. Stem Cell Reports. PMID 31378674 DOI: 10.1016/J.Stemcr.2019.07.006 |
0.303 |
|
| 2018 |
Ohmine S, Salisbury JL, Ingle J, Pettinato G, Haddox CL, Haddad T, Galanis E, Ikeda Y, D'assoro AB. Aurora-A overexpression is linked to development of aggressive teratomas derived from humans iPS cells. Oncology Reports. PMID 29393405 DOI: 10.3892/Or.2018.6239 |
0.708 |
|
| 2017 |
Morsy SG, Tonne JM, Zhu Y, Lu B, Budzik K, Krempski JW, Ali SA, El-Feky MA, Ikeda Y. Divergent susceptibilities to AAV-SaCas9-gRNA vector-mediated genome-editing in a single-cell-derived cell population. Bmc Research Notes. 10: 720. PMID 29221488 DOI: 10.1186/S13104-017-3028-4 |
0.354 |
|
| 2016 |
Hickey RD, Mao SA, Glorioso J, Elgilani F, Amiot B, Chen H, Rinaldo P, Marler R, Jiang H, DeGrado TR, Suksanpaisan L, O'Connor MK, Freeman BL, Ibrahim SH, Peng KW, ... ... Ikeda Y, et al. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1. Science Translational Medicine. 8: 349ra99. PMID 27464750 DOI: 10.1126/Scitranslmed.Aaf3838 |
0.304 |
|
| 2016 |
El Khatib MM, Ohmine S, Jacobus EJ, Tonne JM, Morsy SG, Holditch SJ, Schreiber CA, Uetsuka K, Fusaki N, Wigle DA, Terzic A, Kudva YC, Ikeda Y. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration. Stem Cells Translational Medicine. PMID 26987352 DOI: 10.5966/Sctm.2015-0017 |
0.685 |
|
| 2016 |
Morsy SG, Tonne J, Zhu Y, Belmonte P, Ikeda Y. 543. In Vivo Beta-Cell-Targeted Gene Editing by AAV Vectors Molecular Therapy. 24: S217. DOI: 10.1016/S1525-0016(16)33351-2 |
0.351 |
|
| 2016 |
Schreiber CA, Holditch S, Generous A, Ikeda Y. 297. The Influence of ELABELA AAV Gene Therapy on Cardiorenal Function in Rat Models of Salt-Induced Hypertension and Myocardial Infarction Molecular Therapy. 24: S119. DOI: 10.1016/S1525-0016(16)33106-9 |
0.309 |
|
| 2016 |
Bongers CA, Holditch SJ, Schreiber CA, Konhilas JP, Burnett JC, Ikeda Y. 172. B-Type Natriuretic Peptide Gene Therapy as a Novel Early Treatment for Familial Hypertrophic Cardiomyopathy Molecular Therapy. 24: S67. DOI: 10.1016/S1525-0016(16)32981-1 |
0.305 |
|
| 2016 |
Schreiber CA, Izumiya Y, Asokan A, Ikeda Y. 8. Further Characterization of U2 snRNP Mediated Restriction of AAV Vector Transduction Molecular Therapy. 24: S4-S5. DOI: 10.1016/S1525-0016(16)32817-9 |
0.358 |
|
| 2015 |
Ikeda Y, Makino A, Matchett WE, Holditch SJ, Lu B, Dietz AB, Tomonaga K. A novel intranuclear RNA vector system for long-term stem cell modification. Gene Therapy. PMID 26632671 DOI: 10.1038/Gt.2015.108 |
0.389 |
|
| 2015 |
Schreiber CA, Sakuma T, Izumiya Y, Holditch SJ, Hickey RD, Bressin RK, Basu U, Koide K, Asokan A, Ikeda Y. An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses. Plos Pathogens. 11: e1005082. PMID 26244496 DOI: 10.1371/Journal.Ppat.1005082 |
0.387 |
|
| 2015 |
Holditch SJ, Schreiber CA, Nini R, Tonne JM, Peng KW, Geurts A, Jacob HJ, Burnett JC, Cataliotti A, Ikeda Y. B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival: Novel Model for Human Hypertension. Hypertension. 66: 199-210. PMID 26063669 DOI: 10.1161/Hypertensionaha.115.05610 |
0.727 |
|
| 2015 |
Tonne JM, Sakuma T, Munoz-Gomez M, El Khatib M, Barry MA, Kudva YC, Ikeda Y. Beta cell regeneration after single-round immunological destruction in a mouse model. Diabetologia. 58: 313-23. PMID 25338552 DOI: 10.1007/S00125-014-3416-4 |
0.314 |
|
| 2015 |
Schreiber C, Hackshaw L, Ikeda Y. 87. Towards Renal-Targeted Gene Delivery: Identification of Clades A, B, E and F Adeno-Associated Virus Sequences from Human Urine Samples Molecular Therapy. 23: S37-S38. DOI: 10.1016/S1525-0016(16)33692-9 |
0.318 |
|
| 2015 |
Schreiber C, Sakuma T, Izumiya Y, Holditch S, Hickey R, Bressin R, Basu U, Koide K, Asokan A, Ikeda Y. 41. U2 snRNP Spliceosome Proteins Block Recombinant AAV Vector Transduction Molecular Therapy. 23: S18. DOI: 10.1016/S1525-0016(16)33646-2 |
0.345 |
|
| 2014 |
Sukegawa S, Sakuma R, Ohmine S, Takeuchi H, Ikeda Y, Yamaoka S. Suppressor of cytokine signaling 1 counteracts rhesus macaque TRIM5α-induced inhibition of human immunodeficiency virus type-1 production. Plos One. 9: e109640. PMID 25310711 DOI: 10.1371/Journal.Pone.0109640 |
0.725 |
|
| 2014 |
D'Assoro AB, Liu T, Quatraro C, Amato A, Opyrchal M, Leontovich A, Ikeda Y, Ohmine S, Lingle W, Suman V, Ecsedy J, Iankov I, Di Leonardo A, Ayers-Inglers J, Degnim A, et al. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells. Oncogene. 33: 599-610. PMID 23334326 DOI: 10.1038/Onc.2012.628 |
0.683 |
|
| 2013 |
Tonne JM, Sakuma T, Deeds MC, Munoz-Gomez M, Barry MA, Kudva YC, Ikeda Y. Global gene expression profiling of pancreatic islets in mice during streptozotocin-induced β-cell damage and pancreatic Glp-1 gene therapy. Disease Models & Mechanisms. 6: 1236-45. PMID 23828045 DOI: 10.1242/Dmm.012591 |
0.375 |
|
| 2013 |
Yamada S, Nelson TJ, Kane GC, Martinez-Fernandez A, Crespo-Diaz RJ, Ikeda Y, Perez-Terzic C, Terzic A. Induced pluripotent stem cell intervention rescues ventricular wall motion disparity, achieving biological cardiac resynchronization post-infarction. The Journal of Physiology. 591: 4335-49. PMID 23568891 DOI: 10.1113/Jphysiol.2013.252288 |
0.309 |
|
| 2013 |
Ohmine S, Singh RD, Marks DL, Meyer MA, Pagano RE, Ikeda Y. Viral attachment induces rapid recruitment of an innate immune sensor (TRIM5α) to the plasma membrane. Journal of Innate Immunity. 5: 414-24. PMID 23548691 DOI: 10.1159/000346963 |
0.691 |
|
| 2013 |
Thatava T, Kudva YC, Edukulla R, Squillace K, De Lamo JG, Khan YK, Sakuma T, Ohmine S, Terzic A, Ikeda Y. Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 228-39. PMID 23183535 DOI: 10.1038/Mt.2012.245 |
0.705 |
|
| 2012 |
Kudva YC, Ohmine S, Greder LV, Dutton JR, Armstrong A, De Lamo JG, Khan YK, Thatava T, Hasegawa M, Fusaki N, Slack JM, Ikeda Y. Transgene-free disease-specific induced pluripotent stem cells from patients with type 1 and type 2 diabetes. Stem Cells Translational Medicine. 1: 451-61. PMID 23197849 DOI: 10.5966/Sctm.2011-0044 |
0.681 |
|
| 2012 |
Yu Y, Liu H, Ikeda Y, Amiot BP, Rinaldo P, Duncan SA, Nyberg SL. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies. Stem Cell Research. 9: 196-207. PMID 22885101 DOI: 10.1016/J.Scr.2012.06.004 |
0.364 |
|
| 2012 |
Sakuma T, Barry MA, Ikeda Y. Lentiviral vectors: basic to translational. The Biochemical Journal. 443: 603-18. PMID 22507128 DOI: 10.1042/Bj20120146 |
0.384 |
|
| 2012 |
Ohmine S, Squillace KA, Hartjes KA, Deeds MC, Armstrong AS, Thatava T, Sakuma T, Terzic A, Kudva Y, Ikeda Y. Reprogrammed keratinocytes from elderly type 2 diabetes patients suppress senescence genes to acquire induced pluripotency. Aging. 4: 60-73. PMID 22308265 |
0.683 |
|
| 2012 |
Sakuma T, Tonne JM, Malcolm JA, Thatava T, Ohmine S, Peng KW, Ikeda Y. Long-term infection and vertical transmission of a gammaretrovirus in a foreign host species. Plos One. 7: e29682. PMID 22235324 DOI: 10.1371/Journal.Pone.0029682 |
0.693 |
|
| 2011 |
Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Research & Therapy. 2: 48. PMID 22142803 DOI: 10.1186/Scrt89 |
0.699 |
|
| 2011 |
Ohmine S, Dietz AB, Deeds MC, Hartjes KA, Miller DR, Thatava T, Sakuma T, Kudva YC, Ikeda Y. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells. Stem Cell Research & Therapy. 2: 46. PMID 22088171 DOI: 10.1186/Scrt87 |
0.711 |
|
| 2011 |
Folmes CD, Nelson TJ, Martinez-Fernandez A, Arrell DK, Lindor JZ, Dzeja PP, Ikeda Y, Perez-Terzic C, Terzic A. Somatic oxidative bioenergetics transitions into pluripotency-dependent glycolysis to facilitate nuclear reprogramming. Cell Metabolism. 14: 264-71. PMID 21803296 DOI: 10.1016/J.Cmet.2011.06.011 |
0.327 |
|
| 2011 |
Tonne JM, Campbell JM, Cataliotti A, Ohmine S, Thatava T, Sakuma T, Macheret F, Huntley BK, Burnett JC, Ikeda Y. Secretion of glycosylated pro-B-type natriuretic peptide from normal cardiomyocytes. Clinical Chemistry. 57: 864-73. PMID 21482747 DOI: 10.1373/Clinchem.2010.157438 |
0.678 |
|
| 2011 |
Sakuma T, Hué S, Squillace KA, Tonne JM, Blackburn PR, Ohmine S, Thatava T, Towers GJ, Ikeda Y. No evidence of XMRV in prostate cancer cohorts in the Midwestern United States Retrovirology. 8. PMID 21447170 DOI: 10.1186/1742-4690-8-23 |
0.674 |
|
| 2011 |
Ohmine S, Sakuma R, Sakuma T, Thatava T, Takeuchi H, Ikeda Y. The antiviral spectra of TRIM5α orthologues and human TRIM family proteins against lentiviral production. Plos One. 6: e16121. PMID 21264255 DOI: 10.1371/Journal.Pone.0016121 |
0.71 |
|
| 2011 |
Sakuma T, Tonne JM, Squillace KA, Ohmine S, Thatava T, Peng KW, Barry MA, Ikeda Y. Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahari. Journal of Virology. 85: 1205-13. PMID 21084477 DOI: 10.1128/Jvi.00886-10 |
0.717 |
|
| 2011 |
Thatava T, Nelson TJ, Edukulla R, Sakuma T, Ohmine S, Tonne JM, Yamada S, Kudva Y, Terzic A, Ikeda Y. Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny. Gene Therapy. 18: 283-93. PMID 21048796 DOI: 10.1038/Gt.2010.145 |
0.692 |
|
| 2010 |
Chiriac A, Terzic A, Park S, Ikeda Y, Faustino R, Nelson TJ. SDF-1-enhanced cardiogenesis requires CXCR4 induction in pluripotent stem cells. Journal of Cardiovascular Translational Research. 3: 674-82. PMID 20842469 DOI: 10.1007/S12265-010-9219-1 |
0.372 |
|
| 2010 |
Ohmine S, Sakuma R, Sakuma T, Thatava T, Solis GP, Ikeda Y. Cytoplasmic body component TRIM5{alpha} requires lipid-enriched microdomains for efficient HIV-1 restriction. The Journal of Biological Chemistry. 285: 34508-17. PMID 20810659 DOI: 10.1074/Jbc.M110.158188 |
0.659 |
|
| 2010 |
Sakuma T, De Ravin SS, Tonne JM, Thatava T, Ohmine S, Takeuchi Y, Malech HL, Ikeda Y. Characterization of retroviral and lentiviral vectors pseudotyped with xenotropic murine leukemia virus-related virus envelope glycoprotein. Human Gene Therapy. 21: 1665-73. PMID 20507233 DOI: 10.1089/Hum.2010.063 |
0.717 |
|
| 2010 |
Sakuma R, Sakuma T, Ohmine S, Silverman RH, Ikeda Y. Xenotropic murine leukemia virus-related virus is susceptible to AZT. Virology. 397: 1-6. PMID 19959199 DOI: 10.1016/J.Virol.2009.11.013 |
0.714 |
|
| 2010 |
Sakuma R, Ohmine S, Ikeda Y. Determinants for the rhesus monkey TRIM5alpha-mediated block of the late phase of HIV-1 replication. The Journal of Biological Chemistry. 285: 3784-93. PMID 19951947 DOI: 10.1074/Jbc.M109.059063 |
0.689 |
|
| 2010 |
Iankov ID, Msaouel P, Allen C, Federspiel MJ, Bulur PA, Dietz AB, Gastineau D, Ikeda Y, Ingle JN, Russell SJ, Galanis E. Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer model. Breast Cancer Research and Treatment. 122: 745-54. PMID 19894113 DOI: 10.1007/S10549-009-0602-Z |
0.307 |
|
| 2009 |
Schmeckpeper J, Ikeda Y, Kumar AH, Metharom P, Russell SJ, Caplice NM. Lentiviral tracking of vascular differentiation in bone marrow progenitor cells. Differentiation; Research in Biological Diversity. 78: 169-76. PMID 19715661 DOI: 10.1016/J.Diff.2009.01.002 |
0.334 |
|
| 2009 |
Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism. Circulation Research. 105: 648-56. PMID 19696409 DOI: 10.1161/Circresaha.109.203109 |
0.341 |
|
| 2009 |
Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation. 120: 408-16. PMID 19620500 DOI: 10.1161/Circulationaha.109.865154 |
0.343 |
|
| 2008 |
Greene WC, Debyser Z, Ikeda Y, Freed EO, Stephens E, Yonemoto W, Buckheit RW, Esté JA, Cihlar T. Novel targets for HIV therapy. Antiviral Research. 80: 251-65. PMID 18789977 DOI: 10.1016/J.Antiviral.2008.08.003 |
0.365 |
|
| 2008 |
Sakuma R, Ohmine S, Mael AA, Noser JA, Ikeda Y. Reply to: No effect of endogenous TRIM5α on HIV-1 production Nature Medicine. 14: 236-238. DOI: 10.1038/Nm0308-236 |
0.66 |
|
| 2008 |
Ikeda Y. Trim 5 Alpha-mediated Late Restriction on HIV-1 Production Antiviral Research. 78: A18. DOI: 10.1016/J.Antiviral.2008.01.017 |
0.307 |
|
| 2007 |
Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Wk Lee P, Ikeda Y. The RAS/Raf1/MEK/ERK Signaling Pathway Facilitates VSV-mediated Oncolysis: Implication for the Defective Interferon Response in Cancer Cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1531-1536. PMID 28182875 DOI: 10.1038/sj.mt.6300193 |
0.683 |
|
| 2007 |
Shimojima M, Ikeda Y, Kawaoka Y. The mechanism of Axl-mediated Ebola virus infection. The Journal of Infectious Diseases. 196: S259-63. PMID 17940958 DOI: 10.1086/520594 |
0.385 |
|
| 2007 |
Sakuma R, Mael AA, Ikeda Y. Alpha interferon enhances TRIM5alpha-mediated antiviral activities in human and rhesus monkey cells. Journal of Virology. 81: 10201-6. PMID 17609277 DOI: 10.1128/Jvi.00419-07 |
0.353 |
|
| 2007 |
Noser JA, Mael AA, Sakuma R, Ohmine S, Marcato P, Lee PW, Ikeda Y. The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1531-6. PMID 17505473 DOI: 10.1038/Sj.Mt.6300193 |
0.701 |
|
| 2007 |
Sakuma R, Noser JA, Ohmine S, Ikeda Y. Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins. Nature Medicine. 13: 631-5. PMID 17435772 DOI: 10.1038/Nm1562 |
0.717 |
|
| 2007 |
Sakuma R, Noser JA, Ohmine S, Ikeda Y. Inhibition of HIV-1 replication by simian restriction factors, TRIM5alpha and APOBEC3G. Gene Therapy. 14: 185-9. PMID 16943852 DOI: 10.1038/Sj.Gt.3302852 |
0.722 |
|
| 2006 |
Hasegawa K, Nakamura T, Harvey M, Ikeda Y, Oberg A, Figini M, Canevari S, Hartmann LC, Peng KW. The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6170-8. PMID 17062694 DOI: 10.1158/1078-0432.Ccr-06-0992 |
0.351 |
|
| 2006 |
Noser JA, Towers GJ, Sakuma R, Dumont JM, Collins MKL, Ikeda Y. Cyclosporine increases human immunodeficiency virus type 1 vector transduction of primary mouse cells Journal of Virology. 80: 7769-7774. PMID 16840358 DOI: 10.1128/Jvi.02427-05 |
0.437 |
|
| 2006 |
Naumann N, De Ravin SS, Choi U, Moayeri M, Ikeda Y, Malech HL. Correction of Human X-Linked Chronic Granulomatous Disease (X-CGD) Following Transduction of X-CGD CD34+ Cells with a Modified RD114-Pseudotyped Simian Immunodeficiency Virus Lentiviral Vector in a NOD/SCID Mouse Xenograft Model. Blood. 108: 3278-3278. DOI: 10.1182/Blood.V108.11.3278.3278 |
0.407 |
|
| 2006 |
Moayeri M, De Ravin SS, Kennedy DR, Naumann N, Ikeda Y, Felsburg PJ, Malech HL. Improvement of Canine XSCID by In Vivo Gene Therapy Using RD114/TR-Pseudotyped SIV Lentiviral Vectors. Blood. 108: 3275-3275. DOI: 10.1182/Blood.V108.11.3275.3275 |
0.397 |
|
| 2006 |
Noser JA, Sakuma R, Lee PW, Ikeda Y. 962. The Ras/Raf-1/MEK/ERK Signaling Pathway Dictates Host Cell Permissiveness to VSV Infection Molecular Therapy. 13: S371. DOI: 10.1016/J.Ymthe.2006.08.1054 |
0.342 |
|
| 2005 |
Relander T, Johansson M, Olsson K, Ikeda Y, Takeuchi Y, Collins M, Richter J. Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-, or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Molecular Therapy : the Journal of the American Society of Gene Therapy. 11: 452-9. PMID 15727942 DOI: 10.1016/J.Ymthe.2004.10.014 |
0.396 |
|
| 2005 |
Strang BL, Takeuchi Y, Relander T, Richter J, Bailey R, Sanders DA, Collins MK, Ikeda Y. Human immunodeficiency virus type 1 vectors with alphavirus envelope glycoproteins produced from stable packaging cells. Journal of Virology. 79: 1765-71. PMID 15650201 DOI: 10.1128/Jvi.79.3.1765-1771.2005 |
0.455 |
|
| 2004 |
Ikeda Y, Ylinen LMJ, Kahar-Bador M, Towers GJ. Influence of gag on human immunodeficiency virus type 1 species-specific tropism Journal of Virology. 78: 11816-11822. PMID 15479823 DOI: 10.1128/Jvi.78.21.11816-11822.2004 |
0.427 |
|
| 2004 |
Ikeda Y, Miyazawa T, Nishimura Y, Nakamura K, Tohya Y, Mikami T. High genetic stability of TM1 and TM2 strains of subtype B feline immunodeficiency virus in long-term infection. The Journal of Veterinary Medical Science. 66: 287-9. PMID 15107558 DOI: 10.1292/Jvms.66.287 |
0.301 |
|
| 2004 |
Palmowski MJ, Lopes L, Ikeda Y, Salio M, Cerundolo V, Collins MK. Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response. Journal of Immunology (Baltimore, Md. : 1950). 172: 1582-7. PMID 14734738 DOI: 10.4049/Jimmunol.172.3.1582 |
0.338 |
|
| 2004 |
Strang BL, Ikeda Y, Cosset FL, Collins MK, Takeuchi Y. Characterization of HIV-1 vectors with gammaretrovirus envelope glycoproteins produced from stable packaging cells. Gene Therapy. 11: 591-8. PMID 14724689 DOI: 10.1038/Sj.Gt.3302189 |
0.424 |
|
| 2003 |
Ikeda Y, Takeuchi Y, Martin F, Cosset FL, Mitrophanous K, Collins M. Continuous high-titer HIV-1 vector production Nature Biotechnology. 21: 569-572. PMID 12679787 DOI: 10.1038/Nbt815 |
0.419 |
|
| 2003 |
Kohmoto M, Ikeda Y, Sato E, Nishimura Y, Inoshima Y, Shimojima M, Tohya Y, Mikami T, Miyazawa T. Experimental mucosal infection with molecularly cloned feline immunodeficiency viruses. Clinical and Diagnostic Laboratory Immunology. 10: 185-8. PMID 12522061 DOI: 10.1128/Cdli.10.1.185-188.2003 |
0.345 |
|
| 2002 |
Ikeda Y, Collins MK, Radcliffe PA, Mitrophanous KA, Takeuchi Y. Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Therapy. 9: 932-8. PMID 12085241 DOI: 10.1038/Sj.Gt.3301708 |
0.432 |
|
| 2001 |
Neil S, Martin F, Ikeda Y, Collins M. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes. Journal of Virology. 75: 5448-56. PMID 11356951 DOI: 10.1128/Jvi.75.12.5448-5456.2001 |
0.439 |
|
| 2000 |
Sato E, Yokoyama N, Miyazawa T, Maeda K, Ikeda Y, Nishimura Y, Fujita K, Kohmoto M, Takahashi E, Mikami T. Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline herpesvirus type 1 (FHV-1) using the gC promoter of FHV-1 Virus Research. 70: 13-23. PMID 11074121 DOI: 10.1016/S0168-1702(00)00202-1 |
0.393 |
|
| 2000 |
Nakamura K, Miyazawa T, Ikeda Y, Sato E, Nishimura Y, Nguyen NTP, Takahashi E, Mochizuki M, Mikami T. Contrastive prevalence of feline retrovirus infections between northern and southern Vietnam. Journal of Veterinary Medical Science. 62: 921-923. PMID 10993195 DOI: 10.1292/Jvms.62.921 |
0.33 |
|
| 2000 |
Iwatsuki K, Ikeda Y, Ohashi K, Nakamura K, Kai C. Establishment of a persistent mutant of canine distemper virus. Microbes and Infection. 1: 987-91. PMID 10617930 DOI: 10.1016/S1286-4579(99)80516-4 |
0.395 |
|
| 1999 |
Izumiya Y, Jang H, Sugawara M, Ikeda Y, Miura R, Nishimura Y, Nakamura K, Miyazawa T, Kai C, Mikami T. Identification and transcriptional analysis of the homologues of the herpes simplex virus type 1 UL30 to UL40 genes in the genome of nononcogenic Marek’s disease virus serotype 2 The sequence reported in this paper has been deposited in the GenBank/EMBL/DDBJ databases under accession no. AB024309. Journal of General Virology. 80: 2417-2422. PMID 10501496 DOI: 10.1099/0022-1317-80-9-2417 |
0.349 |
|
| 1999 |
Miyazawa T, Ikeda Y, Nakamura K, Naito R, Mochizuki M, Tohya Y, Vu D, Mikami T, Takahashi E. Isolation of feline parvovirus from peripheral blood mononuclear cells of cats in northern Vietnam. Microbiology and Immunology. 43: 609-612. PMID 10480557 DOI: 10.1111/J.1348-0421.1999.Tb02447.X |
0.365 |
|
| 1999 |
Ikeda Y, Miyazawa T, Nakamura K, Naito R, Inoshima Y, Tung KC, Lee WM, Chen MC, Kuo TF, Lin JA, Mikami T. Serosurvey for Selected Virus Infections of Wild Carnivores in Taiwan and Vietnam Journal of Wildlife Diseases. 35: 578-581. PMID 10479095 DOI: 10.7589/0090-3558-35.3.578 |
0.333 |
|
| 1999 |
Uema M, Ikeda Y, Miyazawa T, Lin aAJ, Chen M, Tkuo z, Kai C, Mikami T, Takahashi E. Feline immunodeficiency virus subtype C is prevalent in northern part of Taiwan. Journal of Veterinary Medical Science. 61: 197-199. PMID 10081765 DOI: 10.1292/Jvms.61.197 |
0.307 |
|
| 1999 |
Nishimura Y, Miyazawa T, Ikeda Y, Izumiya Y, Nakamura K, Cai JS, Sato E, Kohmoto M, Mikami T. Molecular cloning and sequencing of feline CD56 (N-CAM). European Journal of Immunogenetics. 26: 29-32. PMID 10068911 DOI: 10.1046/J.1365-2370.1999.00121.X |
0.32 |
|
| 1999 |
Nishimura Y, Miyazawa T, Ikeda Y, Izumiya Y, Nakamura K, Cai JS, Sato E, Kohmoto M, Mikami T. Molecular cloning and expression of feline CD3epsilon. Veterinary Immunology and Immunopathology. 65: 43-50. PMID 9802575 DOI: 10.1016/S0165-2427(98)00145-7 |
0.351 |
|
| 1999 |
Yamaguchi H, Ikeda Y, Moreno JI, Katsumura M, Miyazawa T, Takahashi E, Imakawa K, Sakai S, Christenson RK. Identification of a functional transcriptional factor AP-1 site in the sheep interferon τ gene that mediates a response to PMA in JEG3 cells Biochemical Journal. 340: 767-773. DOI: 10.1042/0264-6021:3400767 |
0.302 |
|
| 1998 |
Kohmoto M, Miyazawa T, Sato E, Uetsuka K, Nishimura Y, Ikeda Y, Inada G, Doi K, Mikami T. Cats are protected against feline immunodeficiency virus infection following vaccination with a homologous AP-1 binding site-deleted mutant Archives of Virology. 143: 1839-1845. PMID 9787667 DOI: 10.1007/S007050050422 |
0.336 |
|
| 1998 |
Ikeda Y, Miyazawa T, Kurosawa K, Naito R, Hatama S, Kai C, Mikami T. New quantitative methods for detection of feline parvovirus (FPV) and virus neutralizing antibody against FPV using a feline T lymphoid cell line. Journal of Veterinary Medical Science. 60: 973-974. PMID 9764414 DOI: 10.1292/Jvms.60.973 |
0.347 |
|
| 1998 |
Sato E, Yokoyama N, Maeda K, Inoshima Y, Kohmoto M, Ikeda Y, Miyazawa T, Mikami T. Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virus Archives of Virology. 143: 453-466. PMID 9572547 DOI: 10.1007/S007050050302 |
0.377 |
|
| 1998 |
Kohmoto M, Uetsuka K, Ikeda Y, Inoshima Y, Shimojima M, Sato E, Inada G, Toyosaki T, Miyazawa T, Doi K, Mikami T. Eight-year observation and comparative study of specific pathogen-free cats experimentally infected with feline immunodeficiency virus (FIV) subtypes A and B: terminal acquired immunodeficiency syndrome in a cat infected with FIV petaluma strain. Journal of Veterinary Medical Science. 60: 315-321. PMID 9560779 DOI: 10.1292/Jvms.60.315 |
0.339 |
|
| 1998 |
Inoshima Y, Miyazawa T, Kohmoto M, Ikeda Y, Sato E, Hohdatsu T, Mathiason-Dubard C, Hoover EA, Mikami T. Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E. Archives of Virology. 143: 157-62. PMID 9505973 DOI: 10.1007/S007050050275 |
0.315 |
|
| 1998 |
Tomonaga K, Itagaki S-, Kashiwase H, Kawaguchi Y, Inoshima Y, Ikeda Y, Mikami T. Characterization of an integrase mutant of feline immunodeficiency virus Archives of Virology. 143: 1-14. PMID 9505962 DOI: 10.1007/S007050050263 |
0.375 |
|
| 1998 |
Shimojima M, Miyazawa T, Kohmoto M, Ikeda Y, Nishimura Y, Maeda K, Tohya Y, Mikami T. Expansion of CD8alpha+beta- cells in cats infected with feline immunodeficiency virus. Journal of General Virology. 79: 91-94. PMID 9460928 DOI: 10.1099/0022-1317-79-1-91 |
0.302 |
|
| 1997 |
Inada G, Miyazawa T, Inoshima Y, Kohmoto M, Ikeda Y, Liu C-, Lin JA, Kou T-, Mikami T. Phylogenetic analysis of feline immunodeficiency virus isolated from cats in Taiwan. Archives of Virology. 142: 1459-1467. PMID 28879401 DOI: 10.1007/S007050050172 |
0.315 |
|
| 1997 |
Ikeda Y, Kawaguchi Y, Inoshima Y, Kohmoto M, Shimojima M, Inada G, Sato E, Kai C, Miyazawa T, Mikami T. The effects of treatment with chemical agents or infection with feline viruses on protein-binding properties of the feline immunodeficiency virus long terminal repeat Virus Research. 51: 203-212. PMID 9498618 DOI: 10.1016/S0168-1702(97)00094-4 |
0.323 |
|
| 1996 |
Inoshima Y, Kohmoto M, Ikeda Y, Yamada H, Kawaguchi Y, Tomonaga K, Miyazawa T, Kai C, Umemura T, Mikami T. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats Journal of Virology. 70: 8518-8526. PMID 8970975 DOI: 10.1128/Jvi.70.12.8518-8526.1996 |
0.376 |
|
| 1996 |
Inoshima Y, Ikeda Y, Kohmoto M, Pecoraro MR, Shimojima M, Shimojima Y, Inada G, Kawaguchi Y, Tomonaga K, Miyazawa T, Mikami T. Persistence of high virus neutralizing antibody titers in cats experimentally infected with feline immunodeficiency virus. Journal of Veterinary Medical Science. 58: 925-927. PMID 8898296 DOI: 10.1292/Jvms.58.925 |
0.373 |
|
| 1996 |
Ikeda Y, Tomonaga K, Kawaguchi Y, Kohmoto M, Inoshima Y, Tohya Y, Miyazawa T, Kai C, Mikami T. Feline immunodeficiency virus can infect a human cell line (MOLT-4) but establishes a state of latency in the cells Journal of General Virology. 77: 1623-1630. PMID 8760408 DOI: 10.1099/0022-1317-77-8-1623 |
0.421 |
|
| 1996 |
Ikeda Y, Kawaguchi Y, Tomonaga K, Inoshima Y, Kohmoto M, Miyazawa T, Mikami T. Regulatory properties of the integrated long terminal repeat of the feline immunodeficiency virus. Virus Research. 41: 201-207. PMID 8738180 DOI: 10.1016/0168-1702(96)01284-1 |
0.41 |
|
| 1995 |
Kawaguchi Y, Maeda K, Pecoraro MR, Inoshima Y, Jang Hk, Kohmoto M, Iwatsuki K, Ikeda Y, Shimojima M, Tohya Y, Kai C, Mikami T. The Feline Herpesvirus Type 1 ICP4 Down-Regulates Feline Immunodeficiency Virus Long Terminal Repeat (LTR)-Directed Gene Expression Via the C/EBP Site in the LTR Journal of Veterinary Medical Science. 57: 1129-1131. PMID 8720064 DOI: 10.1292/Jvms.57.1129 |
0.336 |
|
| 1995 |
Miyazawa T, Itagaki S, Tomonaga K, Ikeda Y, Mori T, Kawaguchi Y, Gemma T, Tohya Y, Mochizuki M, Mikami T. Establishment of Carrier-State Infection of a Feline Renal Cell Line with Feline Syncytial Virus Journal of Veterinary Medical Science. 57: 65-69. PMID 7756428 DOI: 10.1292/Jvms.57.65 |
0.379 |
|
| 1995 |
Tomonaga K, Inoshima Y, Ikeda Y, Mikami T. Temporal patterns of feline immunodeficiency virus transcripts in peripheral blood cells during the latent stage of infection. Journal of General Virology. 76: 2193-2204. PMID 7561756 DOI: 10.1099/0022-1317-76-9-2193 |
0.414 |
|
| 1995 |
Inoshima Y, Tomonaga K, Ikeda Y, Miyazawa T, Mikami T. Quantification of feline immunodeficiency virus (FIV) proviral DNA in peripheral blood mononuclear cells of cats infected with Japanese strains of FIV. Journal of Veterinary Medical Science. 57: 487-492. PMID 7548402 DOI: 10.1292/Jvms.57.487 |
0.322 |
|
| 1994 |
Miyazawa T, Inoshima Y, Kohmoto M, Ikeda Y, Mikami T. Growth properties of a feline immunodeficiency virus mutant which lacks an AP-1 binding site in primary peripheral blood mononuclear cells. Journal of Veterinary Medical Science. 56: 869-872. PMID 7532437 DOI: 10.1292/Jvms.56.869 |
0.367 |
|
| Show low-probability matches. |